Apr 12 |
Earnings Scheduled For April 12, 2024
|
Apr 12 |
Oncocyte GAAP EPS of -$3.37 misses by $0.87, revenue of $1.5M misses by $0.01M
|
Apr 12 |
Oncocyte Reports Full Year 2023 Financial Results
|
Apr 12 |
Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
|
Apr 12 |
Oncocyte announces $15.8 mln private placement of securities
|
Apr 12 |
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
|
Apr 11 |
Oncocyte stock rallies 90% post-market on Bio-Rad partnership
|
Apr 11 |
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
|
Apr 9 |
Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results
|